Services: Diversified Services

Genetic Technologies Ltd (GENE: NASDAQ)

$2.19 n/a | n/a%
07/22/16 - 04:00 PM ET
Company Cash Flow
Jun 2015 Jun 2014 Jun 2013 Jun 2012
Cash Flow From Operating Activities
Net Income (Loss) -6.76M -9.54M -8.68M -5.42M
Operating Gains/Losses -1.34M 182.50K 405.49K -5.28M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 116.85K -737.12K 155.27K 182.69K
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets -491.00 194.27K -178.00K -15.17K
(Decrease) Increase In Payables -316.20K 69.34K 435.89K -214.30K
(Decrease) Increase In Other Current Liabilities 80.94K -221.81K 14.83K 0.00
(Increase) Decrease In Other Working Capital 591.77K -748.99K 50.23K 194.72K
Other Non-Cash Items 254.55K 156.17K 319.28K 2.18M
Net Cash From Continuing Operations -7.43M -10.34M -6.97M -7.86M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -7.43M -10.34M -6.97M -7.86M
Sale of Property, Plant & Equipment 43.81K 0.00 1.11K 32.21K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -147.72K -45.11K -49.74K -78.15K
Acquisitions 1.61M 0.00 -117.14K 10.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 -172.34K 0.00 549.97K
Cash Provided by Financing Activities
Net Cash From Investing Activities 1.51M 218.78K -165.77K 504.04K
Issuance of Debt 1.65M 5.25M 0.00 1.02M
Cash Used for Financing Activities
Issuance of Capital Stock 17.86M 6.59M 446.78K 11.16M
Repayment of Long-Term Debt 0.00 0.00 -16.47K -1.08M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -1.97M -619.97K -23.94K 0.00
Net Cash From Financing Activities 17.54M 11.23M 406.38K 11.11M
Effect of Exchange Rate Changes 283.11K -55.04K 72.87K 129.54K
Net Change in Cash & Cash Equivalents 11.90M 1.04M -6.66M 3.89M

Portfolios with GENE

Latest GENE Headlines from TheStreet

More Financial News for GENE

Press Releases for GENE

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter